
Daniel M. Sullivan
Director (ID: 12309, Phone: (571)272-0900 , Office: P/1600 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1600, 1611, 1621, 1636 |
| Total Applications | 646 |
| Issued Applications | 156 |
| Pending Applications | 192 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6829721
[patent_doc_number] => 20030180779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Discovery and diagnostic methods using 5-methylcytosine DNA glycosylase'
[patent_app_type] => new
[patent_app_number] => 10/389853
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15130
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10389853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/389853 | Discovery and diagnostic methods using 5-methylcytosine DNA glycosylase | Mar 13, 2003 | Issued |
Array
(
[id] => 7149584
[patent_doc_number] => 20050120404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Cell division and proliferation preferred regulatory elements and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/388359
[patent_app_country] => US
[patent_app_date] => 2003-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8143
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20050120404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10388359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/388359 | Cell division and proliferation preferred regulatory elements and uses thereof | Mar 12, 2003 | Abandoned |
Array
(
[id] => 6729619
[patent_doc_number] => 20030185809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Mixed-cell gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/382137
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10590
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382137
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382137 | Mixed-cell gene therapy | Mar 4, 2003 | Issued |
Array
(
[id] => 7134608
[patent_doc_number] => 20040043394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Gene expression element specific for Ah receptor ligands and heterologous gene expression systems dependent on the element'
[patent_app_type] => new
[patent_app_number] => 10/375269
[patent_app_country] => US
[patent_app_date] => 2003-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9939
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375269 | Gene expression element specific for Ah receptor ligands and heterologous gene expression systems dependent on the element | Mar 2, 2003 | Abandoned |
Array
(
[id] => 6829244
[patent_doc_number] => 20030180302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances'
[patent_app_type] => new
[patent_app_number] => 10/376564
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26651
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10376564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/376564 | Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances | Feb 27, 2003 | Abandoned |
Array
(
[id] => 7679166
[patent_doc_number] => 20030167486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Double transgenic mice overexpressing human beta secretase and human APP-London'
[patent_app_type] => new
[patent_app_number] => 10/372730
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17258
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20030167486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10372730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/372730 | Double transgenic mice overexressing human beta secretase and human APP-London | Feb 23, 2003 | Issued |
Array
(
[id] => 7097699
[patent_doc_number] => 20050130158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Screening method'
[patent_app_type] => utility
[patent_app_number] => 10/502770
[patent_app_country] => US
[patent_app_date] => 2003-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7374
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502770 | Screening method | Feb 17, 2003 | Abandoned |
Array
(
[id] => 6706291
[patent_doc_number] => 20030153025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Cell-based drug screens for regulators of gene expression'
[patent_app_type] => new
[patent_app_number] => 10/365958
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6167
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365958 | Cell-based drug screens for regulators of gene expression | Feb 12, 2003 | Issued |
Array
(
[id] => 6847700
[patent_doc_number] => 20030166867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Fibrin nanoparticles and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/353800
[patent_app_country] => US
[patent_app_date] => 2003-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6226
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353800 | Fibrin nanoparticles and uses thereof | Jan 28, 2003 | Abandoned |
Array
(
[id] => 6658921
[patent_doc_number] => 20030134270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Rapid method of selecting cells for gene disruption by homologous recombination'
[patent_app_type] => new
[patent_app_number] => 10/345130
[patent_app_country] => US
[patent_app_date] => 2003-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8095
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134270.pdf
[firstpage_image] =>[orig_patent_app_number] => 10345130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/345130 | Rapid method of selecting cells for gene disruption by homologous recombination | Jan 13, 2003 | Abandoned |
Array
(
[id] => 7149721
[patent_doc_number] => 20040171061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Cell-free reconstitution of autophagocytosis'
[patent_app_type] => new
[patent_app_number] => 10/240260
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8924
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171061.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240260 | Cell-free reconstitution of autophagocytosis | Jan 8, 2003 | Abandoned |
Array
(
[id] => 7401039
[patent_doc_number] => 20040019002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site'
[patent_app_type] => new
[patent_app_number] => 10/337229
[patent_app_country] => US
[patent_app_date] => 2003-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8961
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10337229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/337229 | Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site | Jan 5, 2003 | Abandoned |
Array
(
[id] => 7116678
[patent_doc_number] => 20050069979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Cell culture process'
[patent_app_type] => utility
[patent_app_number] => 10/497123
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17409
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497123 | Cell culture process | Nov 25, 2002 | Abandoned |
Array
(
[id] => 6661230
[patent_doc_number] => 20030135874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Use of purinergic receptor modulators and related reagents'
[patent_app_type] => new
[patent_app_number] => 10/304157
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8808
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20030135874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304157 | Use of purinergic receptor modulators and related reagents | Nov 25, 2002 | Abandoned |
Array
(
[id] => 6668798
[patent_doc_number] => 20030113782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'MAP4Ks as modifiers of branching morphogenesis and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/303683
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16261
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10303683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/303683 | MAP4Ks as modifiers of branching morphogenesis and methods of use | Nov 24, 2002 | Abandoned |
Array
(
[id] => 6851325
[patent_doc_number] => 20030143528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Vector for analayzing replication mechanism of rna virus and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/276513
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13829
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276513 | Vector for analayzing replication mechanism of rna virus and use thereof | Nov 14, 2002 | Abandoned |
Array
(
[id] => 6847103
[patent_doc_number] => 20030166270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Compositions and methods for reversibly inducing continual growth in normal cells'
[patent_app_type] => new
[patent_app_number] => 10/295681
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19810
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166270.pdf
[firstpage_image] =>[orig_patent_app_number] => 10295681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/295681 | Compositions and methods for reversibly inducing continual growth in normal cells | Nov 14, 2002 | Abandoned |
Array
(
[id] => 537587
[patent_doc_number] => 07176345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor'
[patent_app_type] => utility
[patent_app_number] => 10/287670
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 38
[patent_no_of_words] => 28331
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287670 | Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor | Nov 3, 2002 | Issued |
Array
(
[id] => 6730715
[patent_doc_number] => 20030186905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3\' -untranslated region'
[patent_app_type] => new
[patent_app_number] => 10/169519
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16784
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169519
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169519 | Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region | Oct 29, 2002 | Abandoned |
Array
(
[id] => 6721547
[patent_doc_number] => 20030055237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding secreted proteins and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/274971
[patent_app_country] => US
[patent_app_date] => 2002-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20350
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10274971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/274971 | Isolated human secreted proteins, nucleic acid molecules encoding secreted proteins and uses thereof | Oct 21, 2002 | Abandoned |